Recent Advances in Mitochondria-Targeted Gene Delivery
AbstractMitochondria are the energy-producing organelles of cells. Mitochondrial dysfunctions link to various syndromes and diseases including myoclonic epilepsy and ragged-red fiber disease (MERRF), Leigh syndrome (LS), and Leber hereditary optic neuropathy (LHON). Primary mitochondrial diseases often result from mutations of mitochondrial genomes and nuclear genes that encode the mitochondrial components. However, complete intracellular correction of the mutated genetic parts relevant to mitochondrial structures and functions is technically challenging. Instead, there have been diverse attempts to provide corrected genetic materials with cells. In this review, we discuss recent novel physical, chemical and biological strategies, and methods to introduce genetic cargos into mitochondria of eukaryotic cells. Effective mitochondria-targeting gene delivery systems can reverse multiple mitochondrial disorders by enabling cells to produce functional mitochondrial components. View Full-Text
Share & Cite This Article
Jang, Y.-H.; Lim, K.-I. Recent Advances in Mitochondria-Targeted Gene Delivery. Molecules 2018, 23, 2316.
Jang Y-H, Lim K-I. Recent Advances in Mitochondria-Targeted Gene Delivery. Molecules. 2018; 23(9):2316.Chicago/Turabian Style
Jang, Yoon-ha; Lim, Kwang-il. 2018. "Recent Advances in Mitochondria-Targeted Gene Delivery." Molecules 23, no. 9: 2316.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.